Balancing safety, effectiveness, and public desire: the FDA and cancer.
Conti
Rena
R
John F. Kennedy School of Government, USA.
D000328:Adult; D002648:Child; D002986:Clinical Trials as Topic / Q000191:economics / Q000331:legislation & jurisprudence; D017277:Drug Approval / Q000191:economics / Q000331:legislation & jurisprudence; D015507:Drugs, Investigational / Q000191:economics; D006801:Humans; D018973:Intellectual Property; D007880:Legislation, Drug; D009316:National Institutes of Health (U.S.); D009369:Neoplasms / Q000188:drug therapy*; D012106:Research / Q000191:economics / Q000331:legislation & jurisprudence*; D012449:Safety / Q000191:economics / Q000331:legislation & jurisprudence*; D014481:United States; D014486:United States Food and Drug Administration
D015507:Drugs, Investigational